Severance

Seoul 3722

1 studies enrolling now · 1 studies all time

What they study most

Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Studies at this site

• Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation — Recruiting now